Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
KODK vs TRMK vs HOMB vs XRX vs SFNC
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Information Technology Services
Banks - Regional
KODK vs TRMK vs HOMB vs XRX vs SFNC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Banks - Regional | Banks - Regional | Information Technology Services | Banks - Regional |
| Market Cap | $1.38B | $2.64B | $5.29B | $310M | $3.09B |
| Revenue (TTM) | $1.09B | $1.12B | $1.45B | $7.41B | $627M |
| Net Income (TTM) | $-137M | $224M | $458M | $-1.04B | $-398M |
| Gross Margin | 22.4% | 71.0% | 65.6% | 25.7% | 5.8% |
| Operating Margin | 3.6% | 25.5% | 36.0% | -0.6% | -84.2% |
| Forward P/E | — | 11.5x | 10.8x | 5.1x | 10.3x |
| Total Debt | $250M | $1.12B | $1.20B | $4.25B | $641M |
| Cash & Equiv. | $337M | $668M | $910M | $512M | $380M |
KODK vs TRMK vs HOMB vs XRX vs SFNC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Eastman Kodak Compa… (KODK) | 100 | 570.6 | +470.6% |
| Trustmark Corporati… (TRMK) | 100 | 188.7 | +88.7% |
| Home Bancshares, In… (HOMB) | 100 | 185.6 | +85.6% |
| Xerox Holdings Corp… (XRX) | 100 | 14.9 | -85.1% |
| Simmons First Natio… (SFNC) | 100 | 124.5 | +24.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KODK vs TRMK vs HOMB vs XRX vs SFNC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
KODK is the #2 pick in this set and the best alternative if momentum is your priority.
- +122.5% vs XRX's -53.5%
TRMK ranks third and is worth considering specifically for long-term compounding and valuation efficiency.
- 127.7% 10Y total return vs HOMB's 58.2%
- PEG 1.42 vs HOMB's 3.55
- 34.8% NII/revenue growth vs SFNC's -56.7%
HOMB carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 21 yrs, beta 0.82, yield 2.8%
- Lower volatility, beta 0.82, Low D/E 30.4%, current ratio 0.16x
- NIM 3.8% vs SFNC's 2.9%
- 27.7% margin vs SFNC's -63.4%
XRX is the clearest fit if your priority is growth exposure.
- Rev growth 12.9%, EPS growth 23.3%, 3Y rev CAGR -0.4%
- Lower P/E (5.1x vs 10.8x)
SFNC is the clearest fit if your priority is defensive.
- Beta 1.02, yield 4.0%, current ratio 0.86x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 34.8% NII/revenue growth vs SFNC's -56.7% | |
| Value | Lower P/E (5.1x vs 10.8x) | |
| Quality / Margins | 27.7% margin vs SFNC's -63.4% | |
| Stability / Safety | Beta 0.82 vs XRX's 2.68, lower leverage | |
| Dividends | 2.8% yield, 21-year raise streak, vs XRX's 23.7% | |
| Momentum (1Y) | +122.5% vs XRX's -53.5% | |
| Efficiency (ROA) | 2.0% ROA vs XRX's -10.8%, ROIC 7.2% vs -1.0% |
KODK vs TRMK vs HOMB vs XRX vs SFNC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
KODK vs TRMK vs HOMB vs XRX vs SFNC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HOMB leads in 2 of 6 categories
XRX leads 1 • KODK leads 1 • TRMK leads 0 • SFNC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HOMB leads this category, winning 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XRX is the larger business by revenue, generating $7.4B annually — 11.8x SFNC's $627M. HOMB is the more profitable business, keeping 27.7% of every revenue dollar as net income compared to SFNC's -63.4%. On growth, XRX holds the edge at +26.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $1.1B | $1.5B | $7.4B | $627M |
| EBITDAEarnings before interest/tax | $61M | $323M | $601M | $330M | -$497M |
| Net IncomeAfter-tax profit | -$137M | $224M | $458M | -$1.0B | -$398M |
| Free Cash FlowCash after capex | $466M | $230M | $354M | $267M | $755M |
| Gross MarginGross profit ÷ Revenue | +22.4% | +71.0% | +65.6% | +25.7% | +5.8% |
| Operating MarginEBIT ÷ Revenue | +3.6% | +25.5% | +36.0% | -0.6% | -84.2% |
| Net MarginNet income ÷ Revenue | -12.6% | +20.0% | +27.7% | -14.1% | -63.4% |
| FCF MarginFCF ÷ Revenue | +42.9% | +20.7% | +29.1% | +3.6% | +71.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.3% | — | — | +26.7% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +813.5% | +5.4% | +26.0% | -13.3% | +42.1% |
Valuation Metrics
XRX leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 12.1x trailing earnings, TRMK trades at a 9% valuation discount to HOMB's 13.4x P/E. Adjusting for growth (PEG ratio), TRMK offers better value at 1.50x vs HOMB's 4.39x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.4B | $2.6B | $5.3B | $310M | $3.1B |
| Enterprise ValueMkt cap + debt − cash | $1.3B | $3.1B | $5.6B | $4.0B | $3.4B |
| Trailing P/EPrice ÷ TTM EPS | -7.95x | 12.13x | 13.36x | -0.29x | -7.24x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.50x | 10.82x | 5.14x | 10.35x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.50x | 4.39x | — | — |
| EV / EBITDAEnterprise value multiple | 23.97x | 9.49x | 10.12x | 14.71x | — |
| Price / SalesMarket cap ÷ Revenue | 1.29x | 2.36x | 3.64x | 0.04x | 4.93x |
| Price / BookPrice ÷ Book value/share | 1.78x | 1.28x | 1.36x | 0.45x | 0.84x |
| Price / FCFMarket cap ÷ FCF | 3.10x | 11.39x | 12.53x | 1.20x | 6.88x |
Profitability & Efficiency
HOMB leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
HOMB delivers a 10.9% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-142 for XRX. SFNC carries lower financial leverage with a 0.19x debt-to-equity ratio, signaling a more conservative balance sheet compared to XRX's 6.31x. On the Piotroski fundamental quality scale (0–9), KODK scores 7/9 vs XRX's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -18.7% | +10.8% | +10.9% | -142.4% | -11.6% |
| ROA (TTM)Return on assets | -7.6% | +1.2% | +2.0% | -10.8% | -1.6% |
| ROICReturn on invested capital | +2.1% | +7.1% | +7.2% | -1.0% | -9.1% |
| ROCEReturn on capital employed | +1.6% | +3.2% | +9.8% | -0.9% | -4.2% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 7 | 3 | 4 |
| Debt / EquityFinancial leverage | 0.35x | 0.53x | 0.30x | 6.31x | 0.19x |
| Net DebtTotal debt minus cash | -$87M | $448M | $292M | $3.7B | $261M |
| Cash & Equiv.Liquid assets | $337M | $668M | $910M | $512M | $380M |
| Total DebtShort + long-term debt | $250M | $1.1B | $1.2B | $4.2B | $641M |
| Interest CoverageEBIT ÷ Interest expense | 0.79x | 0.75x | 1.44x | -0.14x | -1.01x |
Total Returns (Dividends Reinvested)
KODK leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in KODK five years ago would be worth $19,437 today (with dividends reinvested), compared to $2,593 for XRX. Over the past 12 months, KODK leads with a +122.5% total return vs XRX's -53.5%. The 3-year compound annual growth rate (CAGR) favors KODK at 61.2% vs XRX's -33.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +67.7% | +15.5% | -3.0% | -2.6% | +14.6% |
| 1-Year ReturnPast 12 months | +122.5% | +32.5% | -1.9% | -53.5% | +16.7% |
| 3-Year ReturnCumulative with dividends | +318.6% | +118.5% | +42.0% | -70.5% | +53.4% |
| 5-Year ReturnCumulative with dividends | +94.4% | +47.6% | +6.6% | -74.1% | -15.4% |
| 10-Year ReturnCumulative with dividends | +20.7% | +127.7% | +58.2% | -42.4% | +25.2% |
| CAGR (3Y)Annualised 3-year return | +61.2% | +29.8% | +12.4% | -33.4% | +15.3% |
Risk & Volatility
Evenly matched — TRMK and HOMB each lead in 1 of 2 comparable metrics.
Risk & Volatility
HOMB is the less volatile stock with a 0.82 beta — it tends to amplify market swings less than XRX's 2.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TRMK currently trades 97.6% from its 52-week high vs XRX's 34.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.68x | 0.94x | 0.82x | 2.68x | 1.02x |
| 52-Week HighHighest price in past year | $14.87 | $45.99 | $30.83 | $6.80 | $22.18 |
| 52-Week LowLowest price in past year | $4.94 | $33.39 | $25.68 | $1.19 | $17.00 |
| % of 52W HighCurrent price vs 52-week peak | +95.2% | +97.6% | +87.1% | +34.9% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 76.2 | 56.0 | 50.3 | 74.8 | 62.3 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 392K | 1.4M | 5.6M | 1.2M |
Analyst Outlook
Evenly matched — HOMB and XRX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TRMK as "Hold", HOMB as "Hold", XRX as "Sell", SFNC as "Buy". Consensus price targets imply 332.5% upside for XRX (target: $10) vs 1.4% for TRMK (target: $46). For income investors, XRX offers the higher dividend yield at 23.69% vs KODK's 0.16%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Sell | Buy |
| Price TargetConsensus 12-month target | — | $45.50 | $32.00 | $10.25 | $22.67 |
| # AnalystsCovering analysts | — | 9 | 19 | 5 | 9 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | +2.2% | +2.8% | +23.7% | +4.0% |
| Dividend StreakConsecutive years of raises | 0 | 1 | 21 | 0 | 6 |
| Dividend / ShareAnnual DPS | $0.02 | $0.97 | $0.75 | $0.56 | $0.85 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.5% | +3.0% | +1.6% | 0.0% | 0.0% |
HOMB leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). XRX leads in 1 (Valuation Metrics). 2 tied.
KODK vs TRMK vs HOMB vs XRX vs SFNC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is KODK or TRMK or HOMB or XRX or SFNC a better buy right now?
For growth investors, Trustmark Corporation (TRMK) is the stronger pick with 34.
8% revenue growth year-over-year, versus -56. 7% for Simmons First National Corporation (SFNC). Trustmark Corporation (TRMK) offers the better valuation at 12. 1x trailing P/E (11. 5x forward), making it the more compelling value choice. Analysts rate Simmons First National Corporation (SFNC) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — KODK or TRMK or HOMB or XRX or SFNC?
On trailing P/E, Trustmark Corporation (TRMK) is the cheapest at 12.
1x versus Home Bancshares, Inc. at 13. 4x. On forward P/E, Xerox Holdings Corporation is actually cheaper at 5. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Trustmark Corporation wins at 1. 42x versus Home Bancshares, Inc. 's 3. 55x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — KODK or TRMK or HOMB or XRX or SFNC?
Over the past 5 years, Eastman Kodak Company (KODK) delivered a total return of +94.
4%, compared to -74. 1% for Xerox Holdings Corporation (XRX). Over 10 years, the gap is even starker: TRMK returned +127. 7% versus XRX's -42. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — KODK or TRMK or HOMB or XRX or SFNC?
By beta (market sensitivity over 5 years), Home Bancshares, Inc.
(HOMB) is the lower-risk stock at 0. 82β versus Xerox Holdings Corporation's 2. 68β — meaning XRX is approximately 228% more volatile than HOMB relative to the S&P 500. On balance sheet safety, Simmons First National Corporation (SFNC) carries a lower debt/equity ratio of 19% versus 6% for Xerox Holdings Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — KODK or TRMK or HOMB or XRX or SFNC?
By revenue growth (latest reported year), Trustmark Corporation (TRMK) is pulling ahead at 34.
8% versus -56. 7% for Simmons First National Corporation (SFNC). On earnings-per-share growth, the picture is similar: Xerox Holdings Corporation grew EPS 23. 3% year-over-year, compared to -343. 8% for Simmons First National Corporation. Over a 3-year CAGR, XRX leads at -0. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — KODK or TRMK or HOMB or XRX or SFNC?
Home Bancshares, Inc.
(HOMB) is the more profitable company, earning 27. 7% net margin versus -63. 4% for Simmons First National Corporation — meaning it keeps 27. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOMB leads at 36. 0% versus -84. 2% for SFNC. At the gross margin level — before operating expenses — TRMK leads at 71. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is KODK or TRMK or HOMB or XRX or SFNC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Trustmark Corporation (TRMK) is the more undervalued stock at a PEG of 1. 42x versus Home Bancshares, Inc. 's 3. 55x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Xerox Holdings Corporation (XRX) trades at 5. 1x forward P/E versus 11. 5x for Trustmark Corporation — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for XRX: 332. 5% to $10. 25.
08Which pays a better dividend — KODK or TRMK or HOMB or XRX or SFNC?
All stocks in this comparison pay dividends.
Xerox Holdings Corporation (XRX) offers the highest yield at 23. 7%, versus 0. 2% for Eastman Kodak Company (KODK).
09Is KODK or TRMK or HOMB or XRX or SFNC better for a retirement portfolio?
For long-horizon retirement investors, Home Bancshares, Inc.
(HOMB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82), 2. 8% yield). Eastman Kodak Company (KODK) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HOMB: +58. 2%, KODK: +20. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between KODK and TRMK and HOMB and XRX and SFNC?
These companies operate in different sectors (KODK (Industrials) and TRMK (Financial Services) and HOMB (Financial Services) and XRX (Technology) and SFNC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: KODK is a small-cap quality compounder stock; TRMK is a small-cap high-growth stock; HOMB is a small-cap deep-value stock; XRX is a small-cap income-oriented stock; SFNC is a small-cap income-oriented stock. TRMK, HOMB, XRX, SFNC pay a dividend while KODK does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.